rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2011-4-27
|
pubmed:abstractText |
The association between human papillomavirus (HPV) and overall survival (OS) in oropharynx cancer (OPC) was retrospectively examined in TAX 324, a phase III trial of sequential therapy for locally advanced head and neck cancer.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1569-8041
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1071-7
|
pubmed:meshHeading |
pubmed-meshheading:21317223-Adult,
pubmed-meshheading:21317223-Aged,
pubmed-meshheading:21317223-Carcinoma, Squamous Cell,
pubmed-meshheading:21317223-Clinical Trials, Phase III as Topic,
pubmed-meshheading:21317223-Disease-Free Survival,
pubmed-meshheading:21317223-Female,
pubmed-meshheading:21317223-Human papillomavirus 16,
pubmed-meshheading:21317223-Humans,
pubmed-meshheading:21317223-Kaplan-Meier Estimate,
pubmed-meshheading:21317223-Male,
pubmed-meshheading:21317223-Middle Aged,
pubmed-meshheading:21317223-Oncogene Proteins, Viral,
pubmed-meshheading:21317223-Oropharyngeal Neoplasms,
pubmed-meshheading:21317223-Papillomavirus E7 Proteins,
pubmed-meshheading:21317223-Papillomavirus Infections,
pubmed-meshheading:21317223-Randomized Controlled Trials as Topic,
pubmed-meshheading:21317223-Repressor Proteins,
pubmed-meshheading:21317223-Retrospective Studies,
pubmed-meshheading:21317223-Tumor Markers, Biological
|
pubmed:year |
2011
|
pubmed:articleTitle |
Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial.
|
pubmed:affiliation |
The Tisch Cancer Institute, Mount Sinai Medical Center, New York, NY, USA. marshall.posner@mssm.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|